Foundation Medicine Coverage Initiated by Cowen

genomeweb
360dx

Foundation Medicine Coverage Initiated by Cowen

Feb 15, 2018

NEW YORK (GenomeWeb) – Cowen today initiated coverage of Foundation Medicine with an Outperform rating for its stock and a target price of $90 per share.

To read the full story....

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Exact Sciences Q1 Revenues Up 87 Percent
Broad Researchers Develop Protocol to Use CRISPR-Based Diagnostic Tool for Zika Testing
CRISPR Company Cofounded by Jennifer Doudna Comes Out of Stealth Mode
Single-Cell Transcriptomes Reveal Cell Differentiation Dynamics in Zebrafish, Frog Embyogenesis
ABRF Speakers Outline Disaster Prep for Core Facilities
Rainbow Genomics, UCLA Partner to Offer Exome Dx in Asia

The Scan

Getting It Early

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

Food Bugs to Meet Sequencers

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

From Ancient Bathrooms

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

This Week in Nature

In Nature this week: ash dieback disease fungal genome, and more.

Main menu